The 6th World Congress on Targeting Phage & Antibiotic Resistance is Back

TID 2023

After a long absence, the 6th World Congress on Targeting Phage &  Antibiotic Resistance is to be held again on June 1-2, 2023 in Paris, France.

This year’s congress will shed light on the aspects of phage therapy today. Academics and industrials will gather to discuss the most recent studies in phage therapy including its pros and cons. The major aim behind  Targeting Phage &  Antibiotic Resistance 2023 is to cover the aspects of phage therapy today, especially with the emergence of phage resistance. It will also highlight the new bacteriophage-based innovations and discoveries. 

The First Speakers

Jessica Sacher, cofounder of Phage Directory, AustraliaScaling Phage Therapy, Starting with Phage Australia
Pranav Johri, Founder of Vitalis Phage Therapy, IndiaFrom Patient to Advocate – Introducing Phage Therapy to India

Lilian Musila, U.S. Army Medical Research Directorate-Africa, Kenya Potential of Therapeutic Phages to Combat MDR ESKAPE Pathogens in Developing Nations

Jean-Paul Pirnay, Queen Astrid Military Hospital Bacteriophages: It’s a medicine, Jim, but not as we know it

Domenico Frezza, University of Roma Tor Vergata, Italy Phage Therapy: Vision and Gaps

Aleksandra Petrovic Fabijan, Westmead Institute for Medical Research, AustraliaTherapeutic Monitoring of Phage Therapy

Abstract Submission

Deadline for Oral Presentation Submission: May 4, 2023
Deadline for Poster Presentation Submission: May 12, 2023

Submission Procedure


Targeting Phage and Antibiotic Resistance will be hybrid. You can choose to register for in-person participation or online participation.

Registration Details


You can reach out to the organizing committee and scientific committee for more information via email: contact[at]